176 related articles for article (PubMed ID: 29253196)
81. MicroRNA networks in FLT3-ITD acute myeloid leukemia.
Hoang DH; Zhao D; Branciamore S; Maestrini D; Rodriguez IR; Kuo YH; Rockne R; Khaled SK; Zhang B; Nguyen LXT; Marcucci G
Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2112482119. PubMed ID: 35412895
[TBL] [Abstract][Full Text] [Related]
82. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease.
Santovito D; Weber C
Nat Rev Cardiol; 2022 Sep; 19(9):620-638. PubMed ID: 35304600
[TBL] [Abstract][Full Text] [Related]
83. Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection.
Fang Q; Chen W; Jian Y; Li Y; Lian W; Wan H; Chen S; Li F; Chen Y
J Healthc Eng; 2022; 2022():8430276. PubMed ID: 35251580
[TBL] [Abstract][Full Text] [Related]
84. TRmir: A Comprehensive Resource for Human Transcriptional Regulatory Information of MiRNAs.
Gao Y; Feng C; Zhang Y; Song C; Chen J; Li Y; Wei L; Qian F; Ai B; Liu Y; Zhu J; Su X; Li C; Wang Q
Front Genet; 2022; 13():808950. PubMed ID: 35186035
[TBL] [Abstract][Full Text] [Related]
85. Molecular Mechanisms of Nutrient-Mediated Regulation of MicroRNAs in Pancreatic β-cells.
Sałówka A; Martinez-Sanchez A
Front Endocrinol (Lausanne); 2021; 12():704824. PubMed ID: 34803905
[TBL] [Abstract][Full Text] [Related]
86. Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies.
Koscianska E; Kozlowska E; Fiszer A
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200099
[TBL] [Abstract][Full Text] [Related]
87. Subcellular Localization of miRNAs and Implications in Cellular Homeostasis.
Jie M; Feng T; Huang W; Zhang M; Feng Y; Jiang H; Wen Z
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34199614
[TBL] [Abstract][Full Text] [Related]
88. Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma.
Huo M; Yu K; Zheng Y; Liu L; Zhao H; Li X; Huang C; Zhang J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151937
[TBL] [Abstract][Full Text] [Related]
89. miRNA interplay: mechanisms and consequences in cancer.
Hill M; Tran N
Dis Model Mech; 2021 Apr; 14(4):. PubMed ID: 33973623
[TBL] [Abstract][Full Text] [Related]
90. Small RNA sequencing reveals distinct nuclear microRNAs in pig granulosa cells during ovarian follicle growth.
Toms D; Pan B; Bai Y; Li J
J Ovarian Res; 2021 Apr; 14(1):54. PubMed ID: 33879202
[TBL] [Abstract][Full Text] [Related]
91. The Risks of miRNA Therapeutics: In a Drug Target Perspective.
Zhang S; Cheng Z; Wang Y; Han T
Drug Des Devel Ther; 2021; 15():721-733. PubMed ID: 33654378
[TBL] [Abstract][Full Text] [Related]
92. Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes.
Simpson K; Conquer-van Heumen G; Watson KL; Roth M; Martin CJ; Moorehead RA
Cancer Cell Int; 2021 Feb; 21(1):89. PubMed ID: 33541373
[TBL] [Abstract][Full Text] [Related]
93. microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma.
Zheng W; Li ZY; Zhao DL; Li XL; Liu R
Cancer Manag Res; 2020; 12():7087-7095. PubMed ID: 32848463
[TBL] [Abstract][Full Text] [Related]
94. Role of the microRNA‑214/Bax axis in the progression of acute liver failure.
Wu S; Huang X; Sun W; Chen L; Huang Y; Wang Y; Luo E; Qin A; Zhao W; Gan J
Mol Med Rep; 2020 Jul; 22(1):117-126. PubMed ID: 32377732
[TBL] [Abstract][Full Text] [Related]
95. MicroRNAs as Emerging Regulators of Signaling in the Tumor Microenvironment.
Syed SN; Brüne B
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32276464
[TBL] [Abstract][Full Text] [Related]
96. miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
Parashar D; Geethadevi A; Aure MR; Mishra J; George J; Chen C; Mishra MK; Tahiri A; Zhao W; Nair B; Lu Y; Mangala LS; Rodriguez-Aguayo C; Lopez-Berestein G; Camara AKS; Liang M; Rader JS; Ramchandran R; You M; Sood AK; Kristensen VN; Mills GB; Pradeep S; Chaluvally-Raghavan P
Cell Rep; 2019 Dec; 29(13):4389-4406.e10. PubMed ID: 31875548
[TBL] [Abstract][Full Text] [Related]
97. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets.
Yang YM; Kim SY; Seki E
Semin Liver Dis; 2019 Feb; 39(1):26-42. PubMed ID: 30809789
[TBL] [Abstract][Full Text] [Related]
98. Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma.
Zhang Y; You W; Zhou H; Chen Z; Han G; Zuo X; Zhang L; Wu J; Wang X
Am J Cancer Res; 2018; 8(10):2116-2129. PubMed ID: 30416861
[TBL] [Abstract][Full Text] [Related]
99. Upregulated miR-1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC.
Zhang Z; Li J; Huang Y; Peng W; Qian W; Gu J; Wang Q; Hu T; Ji D; Ji B; Zhang Y; Wang S; Sun Y
Cell Prolif; 2018 Dec; 51(6):e12505. PubMed ID: 30144184
[TBL] [Abstract][Full Text] [Related]
100. Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level.
Wang D; Sun X; Wei Y; Liang H; Yuan M; Jin F; Chen X; Liu Y; Zhang CY; Li L; Zen K
Nucleic Acids Res; 2018 Feb; 46(4):2012-2029. PubMed ID: 29253196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
